---
type: "Bill"
title: "Relates to brand-name drugs with and without an AB generic equivalent"
description: "Relates to brand-name drugs with and without an AB generic equivalent; amends the effective date from January to July next succeeding the date on which it shall have become a law."
jurisdiction: "us/states/ny"
legislature: "New York Legislature"
session: "2023-2024"
identifier: "S 1350"
citation: "New York S 1350 (2023-2024)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Gustavo Rivera"]
version_count: 1
action_count: 11
vote_count: 3
first_action: "2023-01-11"
last_action: "2023-03-24"
source: "openstates"
source_identifier: "ocd-bill/de4e4518-1bff-45da-8ad2-77cecaa6ab92"
source_url: "http://www.nysenate.gov/legislation/bills/2023/S1350"
source_hash: "66989df6230069a9d6e0fd9f4ea385d5269b1f61e7e02a3dbe53bbe81d3ccbf7"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-ny"]
---

# New York S 1350 (2023-2024) — Relates to brand-name drugs with and without an AB generic equivalent

Relates to brand-name drugs with and without an AB generic equivalent; amends the effective date from January to July next succeeding the date on which it shall have become a law.

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **S1350** (committee substitute) — [source](http://assembly.state.ny.us/leg/?sh=printbill&bn=S1350&term=2023&Text=Y)

## Votes

- Assembly Vote — **138–0** (pass) · lower
- Rules Vote — **20–0** (pass) · upper
- Floor Vote — **63–0** (pass) · upper

## Sponsors

- Gustavo Rivera — primary (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2023-01-11** REFERRED TO RULES `referral-committee`
- **2023-01-17** ORDERED TO THIRD READING CAL.118
- **2023-02-01** PASSED SENATE `passage`
- **2023-02-01** DELIVERED TO ASSEMBLY
- **2023-02-01** REFERRED TO INSURANCE `referral-committee`
- **2023-03-09** SUBSTITUTED FOR A3693
- **2023-03-09** ORDERED TO THIRD READING CAL.40
- **2023-03-09** PASSED ASSEMBLY `passage`
- **2023-03-09** RETURNED TO SENATE
- **2023-03-24** DELIVERED TO GOVERNOR `executive-receipt`
- **2023-03-24** SIGNED CHAP.117 `executive-signature`

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/de4e4518-1bff-45da-8ad2-77cecaa6ab92`. Confidence: reported (aggregated from official New York legislature records).